Literature DB >> 16799769

Phytanic acid: production from phytol, its breakdown and role in human disease.

D M van den Brink1, R J A Wanders.   

Abstract

Phytanic acid is a branched-chain fatty acid that accumulates in a variety of metabolic disorders. High levels of phytanic acid found in patients can exceed the millimolar range and lead to severe symptoms. Degradation of phytanic acid takes place by alpha-oxidation inside the peroxisome. A deficiency of its breakdown, leading to elevated levels, can result from either a general peroxisomal dysfunction or from a defect in one of the enzymes involved in alpha-oxidation. Research on Refsum disease, belonging to the latter group of disorders and characterized by a deficiency of the first enzyme of alpha-oxidation, has extended our knowledge of phytanic acid metabolism and pathology of the disease greatly over the past few decades. This review will centre on this research on phytanic acid: its origin, the mechanism by which its alpha-oxidation takes place, its role in human disease and the way it is produced from phytol.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16799769     DOI: 10.1007/s00018-005-5463-y

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  33 in total

1.  Estimated phytanic acid intake and prostate cancer risk: a prospective cohort study.

Authors:  Margaret E Wright; Phyllis Bowen; Jarmo Virtamo; Demetrius Albanes; Peter H Gann
Journal:  Int J Cancer       Date:  2012-01-24       Impact factor: 7.396

Review 2.  Metabolite transport across the peroxisomal membrane.

Authors:  Wouter F Visser; Carlo W T van Roermund; Lodewijk Ijlst; Hans R Waterham; Ronald J A Wanders
Journal:  Biochem J       Date:  2007-01-15       Impact factor: 3.857

Review 3.  Recognition and diagnosis of neuro-ichthyotic syndromes.

Authors:  William B Rizzo; Sabrina Malone Jenkens; Philip Boucher
Journal:  Semin Neurol       Date:  2012-03-15       Impact factor: 3.420

4.  Ultrastructure of skin from Refsum disease with emphasis on epidermal lamellar bodies and stratum corneum barrier lipid organization.

Authors:  G K Menon; E Orsó; Charalampos Aslanidis; D Crumrine; G Schmitz; Peter M Elias
Journal:  Arch Dermatol Res       Date:  2014-06-12       Impact factor: 3.017

5.  Phytanic acid attenuates insulin-like growth factor-1 activity via nitric oxide-mediated γ-secretase activation in rat aortic smooth muscle cells: possible implications for pathogenesis of infantile Refsum disease.

Authors:  Gursev S Dhaunsi; Mayra Alsaeid; Saghir Akhtar
Journal:  Pediatr Res       Date:  2016-11-25       Impact factor: 3.756

6.  ACOX2 deficiency: A disorder of bile acid synthesis with transaminase elevation, liver fibrosis, ataxia, and cognitive impairment.

Authors:  Sílvia Vilarinho; Sinan Sari; Francesca Mazzacuva; Kaya Bilgüvar; Güldal Esendagli-Yilmaz; Dhanpat Jain; Gülen Akyol; Buket Dalgiç; Murat Günel; Peter T Clayton; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-19       Impact factor: 11.205

7.  Impact of dietary phytol on lipid metabolism in SCP2/SCPX/L-FABP null mice.

Authors:  Sherrelle Milligan; Gregory G Martin; Danilo Landrock; Avery L McIntosh; John T Mackie; Friedhelm Schroeder; Ann B Kier
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2016-12-06       Impact factor: 4.698

8.  The WW domain protein PRO40 is required for fungal fertility and associates with Woronin bodies.

Authors:  Ines Engh; Christian Würtz; Konstanze Witzel-Schlömp; Hai Yu Zhang; Birgit Hoff; Minou Nowrousian; Hanspeter Rottensteiner; Ulrich Kück
Journal:  Eukaryot Cell       Date:  2007-03-09

9.  Various Terpenoids Derived from Herbal and Dietary Plants Function as PPAR Modulators and Regulate Carbohydrate and Lipid Metabolism.

Authors:  Tsuyoshi Goto; Nobuyuki Takahashi; Shizuka Hirai; Teruo Kawada
Journal:  PPAR Res       Date:  2010-06-03       Impact factor: 4.964

10.  Infantile Refsum Disease: Influence of Dietary Treatment on Plasma Phytanic Acid Levels.

Authors:  Maria João Nabais Sá; Júlio C Rocha; Manuela F Almeida; Carla Carmona; Esmeralda Martins; Vasco Miranda; Miguel Coutinho; Rita Ferreira; Sara Pacheco; Francisco Laranjeira; Isaura Ribeiro; Ana Maria Fortuna; Lúcia Lacerda
Journal:  JIMD Rep       Date:  2015-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.